Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¾ç¼º, ºñÀüÇüÀû, ±×¸®°í ¾Ç¼º ³ú¼ö¸·Á¾¿¡¼­ ¾ÏÀ¯ÀüÀÚ ¹× p53 ´Ü¹é ¹ßÇöÀÇ ¸é¿ªÁ¶Á÷È­ÇÐÀû ºÐ¼® Immunohistochemical Evaluation of Oncogenes and p53 Protein Expression in Benign, Atypical and Malignant Meningiomas

´ëÇѽŰæ¿Ü°úÇÐȸÁö 1998³â 27±Ç 4È£ p.438 ~ 446
¿©Àοí, ±èÁ¤ÈÆ, ±Çº´´ö, ¼­ÀçÈñ,
¼Ò¼Ó »ó¼¼Á¤º¸
¿©Àοí (  ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç

±èÁ¤ÈÆ (  ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç
±Çº´´ö (  ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ ½Å°æ¿Ü°úÇб³½Ç
¼­ÀçÈñ (  ) 
¿ï»ê´ëÇб³ ÀÇ°ú´ëÇÐ Áø´Üº´¸®Çб³½Ç

Abstract

³ú¼ö¸·Á¾Àº ±âº»ÀûÀ¸·Î ¾ç¼º Á¾¾çÀÌ¸ç ´ëºÎºÐÀÇ °æ¿ì ¼ö¼ú¿¡ ÀÇÇÏ¿© ¿ÏÄ¡µÉ ¼ö ÀÖ´Â Á¾¾ç
ÀÌ´Ù. ±×·¯³ª °æ¿ì¿¡ µû¶ó¼­ ¾î¶² Á¾¾çÀº ¼ö¼úÀÌ ºÒ°¡´ÉÇÏ°í °ø°ÝÀûÀÌ¸ç ¼ö¼úÀû óġ·Î´Â
Ä¡·á°¡ ºÒ°¡´ÉÇÏ´Ù ÀϹÝÀûÀ¸·Î Á¶Á÷ÇÐÀû Áø´Ü¸¸À¸·Î Á¤È®ÇÏ°Ô ³ú¼ö¸·Á¾ÀÇ »ý¹°ÇÐÀûÀÎ Çൿ
¾çŸ¦ ±ÔÁ¤Çϱ⿡´Â ºÎÀûÀý ÇÏ´Ù°í ¾Ë·ÁÁ® ÀÖÀ¸¸ç, µû¶ó¼­ ÃÖ±Ù ³ú¼ö¸·Á¾¿¡ ´ëÇÑ »ýÈ­ÇÐÀû
¹× »ý¹°ÇÐÀûÀÎ ºÐ¼®ÀÌ ¸¹ÀÌ ½ÃµµµÇ°í ÀÖ´Ù. ÀúÀÚµéÀº À¯Àü ÀÎÀÚµéÀÇ ºñÁ¤»óÀûÀÎ ¹ßÇöÀÌ ³ú
¼ö¸·Á¾ÀÇ ¾Ç¼ºµµ¿Í °ü·ÃÀÌ ÀÖ´ÂÁö °áÁ¤Çϱâ À§ÇÏ¿© ¸é¿ªÁ¶Á÷È­ÇÐÀû ºÐ¼®À» ÀÌ¿ëÇÏ¿© 47¿¹ÀÇ
³ú¼ö¸·Á¾(6 :¾Ç¼º. 14 : ºñÀüÇüÀû 27 ÀÓÀÇ·Î ÃßÃâÇÑ ¾ç¼º ¼ö¸·Á¾)¿¡ ´ëÇØ¿© ´Ù¾çÇÑ ¾Ï À¯Àü
ÀÎÀÚ ¹× p53´Ü¹éÀ» ºÐ¼®ÇÏ¿´´Ù. ¸¹Àº ¾ÏÀ¯ÀüÀÚµé Áß¿¡¼­ erb B-2¿Í bFGFÀÇ ¹ßÇöÀº ³ú¼ö¸·
Á¾ÀÇ ¾Ç¼ºµµ¿Í °ü·ÃÀÌ ÀÖ¾ú´Ù. ±×·¯³ª, ±× ÀÌ¿ÜÀÇ ´Ù¸¥ ¾Ï À¯ÀüÀÚµé¹× pS3´Ü¹é ¹ßÇöÀº ³ú¼ö
¸·Á¾ÀÇ ¾Ç¼ºµµ¿Í °ü·ÃÀÌ ¾ø¾ú´Ù. ÀúÀÚµéÀº ³ú¼ö¸·Á¾ÀÇ ¹ß»ý±âÀü»Ó¸¸ ¾Æ´Ï¶ó °ø°Ý¼ºÀ̳ª Àç
¹ßÀÇ °¡´É¼º¿¡ °üÇÑ ¿¹Èĸ¦ º¸´Ù Á¤È®È÷ Çϱâ À§ÇÏ¿© Áö¼ÓÀûÀÎ ºÐÀÚÀ¯ÀüÇÐÀû ¿¬±¸°¡ ÀÌ·ç¾î
Á®¾ß ÇÑ´Ù°í »ý°¢ÇÑ´Ù.
#ÃÊ·Ï#
Meningiomas are primarily benign, mesenchymal tumors which in most cases can be
surgically removed. Some tumors, however, are inoperable or invasive, and histology
alone may be insufficient to characterized their biologic behavior. Thus, there is a need
for a more effective means of differentiation between benign and atypical/malignant
meningiomas. To determine whether abnormal gene expression correlates with the
histologic grade of meningiomas, we immunohistochemically analyzed the expression of
multiple oncogenes and p53 protein in 47 meningioma tissue specimens ; six were
malignant, 14 were atypical, and 27 we randomly sampled were benign. The specimens
were on paraffin-embedded tissue sections and monoclonal antibody was used. The
results are summarized as follows : 1) among multiple oncogene factors, erb B-2 and
FGF expression was associated with malignancy, 2) p53 protein expression did not
correlate with histologic grade. We believe that not only for a better understanding of
the mechanism of oncogenesis, but also to justify the prognostic significance of
aggressive or potential for recurrence, further investigation of the molecular genetic of
meningiomas is required.

Å°¿öµå

Meningioma; Atypical/malignant; Oncogenes; p53 protein; Immunohistochemistry; Molecular genetics.;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS